- Home
- EXEL vs SPXC Comparison
EXEL vs SPXC Comparison
Compare EXEL & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- SPXC
- Stock Information
- Founded
- EXEL 1994
- SPXC 1912
- Country
- EXEL United States
- SPXC United States
- Employees
- EXEL N/A
- SPXC N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- SPXC Industrial Machinery/Components
- Sector
- EXEL Health Care
- SPXC Industrials
- Exchange
- EXEL Nasdaq
- SPXC Nasdaq
- Market Cap
- EXEL 10.4B
- SPXC 9.2B
- IPO Year
- EXEL 2000
- SPXC N/A
- Fundamental
- Price
- EXEL $37.88
- SPXC $187.82
- Analyst Decision
- EXEL Buy
- SPXC Strong Buy
- Analyst Count
- EXEL 21
- SPXC 4
- Target Price
- EXEL $43.65
- SPXC $200.25
- AVG Volume (30 Days)
- EXEL 2.4M
- SPXC 531.2K
- Earning Date
- EXEL 10-28-2025
- SPXC 10-29-2025
- Dividend Yield
- EXEL N/A
- SPXC N/A
- EPS Growth
- EXEL 81.76
- SPXC 100.86
- EPS
- EXEL 2.08
- SPXC 4.47
- Revenue
- EXEL $2,230,005,000.00
- SPXC $2,052,400,000.00
- Revenue This Year
- EXEL $9.24
- SPXC $15.43
- Revenue Next Year
- EXEL $13.04
- SPXC $8.03
- P/E Ratio
- EXEL $18.24
- SPXC $41.84
- Revenue Growth
- EXEL 10.73
- SPXC 8.90
- 52 Week Low
- EXEL $25.12
- SPXC $115.00
- 52 Week High
- EXEL $49.62
- SPXC $209.38
- Technical
- Relative Strength Index (RSI)
- EXEL 44.99
- SPXC 51.29
- Support Level
- EXEL $36.23
- SPXC $181.43
- Resistance Level
- EXEL $38.95
- SPXC $193.00
- Average True Range (ATR)
- EXEL 0.85
- SPXC 3.28
- MACD
- EXEL 0.13
- SPXC -1.16
- Stochastic Oscillator
- EXEL 60.66
- SPXC 55.19
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SPXC SPX Technologies Inc.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.